These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28400153)

  • 21. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
    Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
    [No Abstract]   [Full Text] [Related]  

  • 22. Genome network medicine: innovation to overcome huge challenges in cancer therapy.
    Roukos DH
    Wiley Interdiscip Rev Syst Biol Med; 2014; 6(2):201-8. PubMed ID: 24318985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bulk and Single-Cell Next-Generation Sequencing: Individualizing Treatment for Colorectal Cancer.
    Kyrochristos ID; Ziogas DE; Goussia A; Glantzounis GK; Roukos DH
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31752125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Next generation zebrafish-based drug discovery and precision medicine].
    Tanaka T; Koiwa J
    Nihon Yakurigaku Zasshi; 2019; 154(2):78-83. PubMed ID: 31406047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
    Gupta RG; Somer RA
    Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outlier analysis of functional genomic profiles enriches for oncology targets and enables precision medicine.
    Zhu Z; Ihle NT; Rejto PA; Zarrinkar PP
    BMC Genomics; 2016 Jun; 17():455. PubMed ID: 27296290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of tumor sequencing on the use of anticancer drugs.
    Thomas F; Desmedt C; Aftimos P; Awada A
    Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next-generation sequencing: hype and hope for development of personalized radiation therapy?
    Tinhofer I; Niehr F; Konschak R; Liebs S; Munz M; Stenzinger A; Weichert W; Keilholz U; Budach V
    Radiat Oncol; 2015 Aug; 10():183. PubMed ID: 26316159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
    Yeang CH; Beckman RA
    Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precision medicine and bladder cancer heterogeneity.
    Ma G; Yang X; Liang Y; Wang L; Li D; Chen Y; Liang Z; Wang Y; Niu H
    Bull Cancer; 2018 Oct; 105(10):925-931. PubMed ID: 30243478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The challenges of tumor genetic diversity.
    Mroz EA; Rocco JW
    Cancer; 2017 May; 123(6):917-927. PubMed ID: 27861749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
    Sheikine Y; Kuo FC; Lindeman NI
    J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic Analyses and Precision Oncology in Gastroesophageal Cancer: Forwards or Backwards?
    Sundar R; Tan P
    Cancer Discov; 2018 Jan; 8(1):14-16. PubMed ID: 29311223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumor and circulating clonal heterogeneity shape the basis of precision breast cancer therapy.
    Ziogas DE; Spiliotis J; Lykoudis EG; Zografos GC; Roukos DH
    Future Oncol; 2017 Jan; 13(2):113-116. PubMed ID: 27581662
    [No Abstract]   [Full Text] [Related]  

  • 37. Tumor heterogeneity-driven individualized therapy.
    Baltagiannis EG; Ziogas DE; Cho WC; Mitsis M; Roukos DH
    Future Oncol; 2021 Jan; 17(3):235-240. PubMed ID: 33305621
    [No Abstract]   [Full Text] [Related]  

  • 38. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.
    Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM
    Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?
    Falk AT; Heeke S; Hofman V; Lespinet V; Ribeyre C; Bordone O; Poudenx M; Otto J; Garnier G; Castelnau O; Guigay J; Leroy S; Marquette CH; Hofman P; Ilié M
    Expert Rev Anticancer Ther; 2017 Aug; 17(8):681-685. PubMed ID: 28511612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution.
    McGranahan N; Swanton C
    Cancer Cell; 2015 Jan; 27(1):15-26. PubMed ID: 25584892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.